| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.095 | 0.002 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.37 | 0.002 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.097 | 0.002 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |